Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Berrin Tunca

8PUBLICATIONS
32CO-AUTHORS
Haematological tumoursPaediatrics not elsewhere classifiedMolecular targetsEcosystem services (incl. pollination)Natural products and bioactive compounds
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Mar 31, 2026
The MALAT1-EZH2 axis regulates PRC2 activity and promotes the mesenchymal phenotype in pediatric atypical teratoid/rhabdoid tumors.

Melisa Gurbuz, Cagla Tekin, Melis Ercelik

|Feb 25, 2026
Identification of the Philadelphia-like subgroup in Turkish pediatric patients with acute lymphoblastic leukemia.

Ecem Efendi Erdem, Gulsah Cecener, Ufuk Unal

|Jan 30, 2026
Overcoming Intrinsic and Acquired Temozolomide Resistance in Glioblastoma: Fisetin as a Potential Strategy to Enhance Sensitivity via ZEB1 Modulation.

Sena Ferah, Mine Çamlıbel, Melis Erçelik

|May 10, 2023
<i>Olea europaea</i> L. Leaf Extract Attenuates Temozolomide-Induced Senescence-Associated Secretion Phenotype in Glioblastoma.

Melis Erçelik, Berrin Tunca, Seçil Ak Aksoy

|Feb 25, 2023
<i>Olea europaea</i> Leaf Phenolics Oleuropein, Hydroxytyrosol, Tyrosol, and Rutin Induce Apoptosis and Additionally Affect Temozolomide against Glioblastoma: In Particular, Oleuropein Inhibits Spheroid Growth by Attenuating Stem-like Cell Phenotype.

Melis Ercelik, Cagla Tekin, Gulcin Tezcan

|Jul 06, 2022
Early-stage colon cancer with high MALAT1 expression is associated with the 5-Fluorouracil resistance and future metastasis.

Secil Ak Aksoy, Berrin Tunca, Melis Erçelik

Pageof 2

Frequent Collaborators

4 joint publications

Gulcin Tezcan

3 joint publications

Unal Egeli

3 joint publications

Çağla Tekin

3 joint publications

Melis Erçelik

2 joint publications

Ufuk Unal

2 joint publications

Gulsah Cecener

2 joint publications

Havva Tezcan Unlu

2 joint publications

Ecem Efendi Erdem

2 joint publications

Mevlut Ozgur Taskapilioglu

2 joint publications

Secil Ak Aksoy

Frequent Collaborators

4 joint publications

Gulcin Tezcan

3 joint publications

Unal Egeli

3 joint publications

Çağla Tekin

3 joint publications

Melis Erçelik

Top Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on : Apr 07, 2017

9.9K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on : Oct 17, 2025

764
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.6K
See more related videos

Top Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on : Apr 07, 2017

9.9K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on : Oct 17, 2025

764
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.6K
See more related videos